RNA Overview
Upcoming Projects (RNA)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (RNA)
-
Reviewing the recent Duchenne Muscular Dystrophy Data from Wave Life Sciences on their exon 53 skipper, WVE-N531
Tickers: WVE, SRPT, RNA, NS Pharma
Executed On: Sep 26, 2024 at 11:00 AM EDT -
A Second Look: Reviewing Avidity Biosciences Phase 1/2 FORTITUDE trial of AAOC- 1020 (del-brax) for FSHD
Tickers: RNA, FULC
Executed On: Aug 28, 2024 at 02:00 PM EDT -
Reviewing Avidity Bioscience's Phase 1/2 data from their Explore 44 Trial of AOC 1044 for Duchenne Muscular Dystrophy treatment
Tickers: RNA, SRPT
Executed On: Aug 15, 2024 at 04:00 PM EDT -
Reviewing Avidity Biosciences Phase 1/2 FORTITUDE trial of AAOC- 1020 (del-brax) for FSHD
Tickers: RNA, FULC
Executed On: Jul 09, 2024 at 11:00 AM EDT -
Discussing the different therapeutic approaches from Fulcrum Therapeutics and Arrowhead Pharmaceuticals for the treatment of Facioscapulohumeral muscular dystrophy (FSHD)
Tickers: ARWR, RNA, FULC
Executed On: Jun 18, 2024 at 12:00 PM EDT -
A Second View: Delving into the MARINA Phase 1/2 clinical trial data on Avidity Biosciences' AOC 1001 in treating Myotonic Dystrophy
Ticker: RNA
Executed On: Feb 10, 2023 at 11:00 AM EST -
Delving into the MARINA Phase 1/2 clinical trial data on Avidity Biosciences' AOC 1001 in treating Myotonic Dystrophy.
Ticker: RNA
Executed On: Jan 30, 2023 at 02:00 PM EST
Upcoming & Overdue Catalysts (RNA)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (RNA)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
